• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Skye Bioscience Inc (NQ: SKYE )

    5.370 +0.020 (+0.37%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Skye Bioscience Inc

    MarketBeat Week in Review – 10/7 - 10/11
    Stocks delivered another winning week, but the latest inflation readings dampened hopes for aggressive rate cuts and turned attention toward earnings 
    Via MarketBeat
    Topics Artificial Intelligence Economy
    Exposures Artificial Intelligence Economy Interest Rates
    Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar
    Skye Bioscience has incredible potential upside, according to Wall Street analysts. It is striving to make a new weight loss drug, that could work with GLP-1s. 
    Via MarketBeat
    3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore
    Check out these three micro-cap companies that have a big opportunity to succeed, but also significant a risk of failure. 
    Via MarketBeat
    Topics Bankruptcy
    Exposures Financial Legal
    Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
    Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus... 
    Via Benzinga
    US Stocks Edge Lower; FedEx Earnings Miss Views
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    SKYE Investors Have Opportunity to Join Skye Bioscience, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
    From Beacon Biosignals
    Via GlobeNewswire
    3 Biotech Stocks That Can Gain Exponentially By Leveraging AI
    Although fraught with risk, these biotech exposures bring enormous upside potential. 
    Via Talk Markets
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
    The company is focusing on obesity treatment after its glaucoma drug failed. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Perion Network Cuts Revenue Outlook, Joins Skye Bioscience And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
    Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game. 
    Via InvestorPlace
    Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
    These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank? 
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.